In mesenchymal cancer stem cells, overexpression of NNMT leads to depletion of intracellular NAM, resulting in increased PARP1 activity and enhanced resistance of cancer cells to chemoradiotherapy.[16, 45] Ulanovskaya et al. The gene discussed is NNMT; the disease is cancer.